Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance

FEMS Microbiology Reviews

Volumn 36, Issue 2, 2012, Pages 288-305

  Silva, Sónia ^a   Negri, Melyssa ^a   Henriques, Mariana ^a   Oliveira, Rosário ^a   Williams, David W ^b   Azeredo, Joana ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antifungal resistance; Candida species; Candidosis; Epidemiology; Virulence factors

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; HYDROLASE; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIMICROBIAL THERAPY; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CANDIDIASIS; CANDIDURIA; CELL ADHESION; FUNGAL VIRULENCE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; HUMAN; INFECTION RISK; MICROBIAL SENSITIVITY TEST; MICROMORPHOLOGY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; THRUSH;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; HUMANS;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI;

EID: 84856690332     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/j.1574-6976.2011.00278.x     Document Type: Review

References (165)

1. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H & Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis24: 1122-1128.
2. Alexander BD, Ashley ED, Reller LB & Reed SD (2006) Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagn Micr Infec Dis54: 277-282.
3. Al-Fattani MA & Douglas LJ (2006) Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 55: 999-1008.
4. Allesen-Holm M, Barken KB, Yang Let al. (2006) A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol59: 1114-1128.
5. Almirante B, Rodriguez D, Cuenca-Estrella Met al. (2006) Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 44: 1681-1685.
6. Álvarez-Lerma F, Nolla-Salas J, León C, Palomar M, Jordá R, Carrasco N & Bobillo F (2003) Candiduria in critically ill patients admitted to intensive care medical units. Intens Care Med29: 1069-1076.
7. Anil S, Ellepola AN & Samaranayake LP (2001) The impact of chlorhexidine gluconate on the relative cell surface hydrophobicity of oral Candida albicans. Oral Dis7: 119-122.
8. Atkinson GW & Israel HL (1973) 5-Fluorocytosine treatment of meningeal and pulmonary aspergillosis. Am J Med55: 496.
9. Baillie GS & Douglas LJ (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemoth46: 397-403.
10. Bassetti M, Righi E, Costa A, Fasce R, Molinari M, Rosso R & Viscoli C (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis6: 21.
11. Bayegan S, Majoros L, Kardos L, Kemény-Beke A, Miszti C, Kovacs R & Gesztelyi R (2010) In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin. J Microbiol48: 170-173.
12. Benjamin DK, Ross K, McKinney RE, Benjamin DK, Auten R & Fisher RG (2000) When to suspect fungal infection in neonates: a clinical comparison of Candidaalbicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 106: 712-718.
13. Binelli CA, Moretti ML, Assis RSet al. (2006) Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infec12: 538-543.
14. Bonassoli LA, Bertoli M & Svidzinski TIE (2005) High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect59: 159-162.
15. Borg M & Ruchel R (1990) Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis. J Med Vet Mycol28: 3-14.
16. Brito LR, Guimaraes T, Nucci M, Rosas RC, Almeida PL, Matta DA & Colombo AL (2006) Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol44: 261-266.
17. Butler G, Rasmussen MD, Lin MFet al. (2009) Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature459: 657-662.
18. Cafarchia C, Romito D, Coccioli C, Camarda A & Otranto D (2008) Phospholipase activity of yeasts from wild birds and possible implications for human disease. Med Mycol46: 429-434.
19. Calderone RA (2002) Introduction and historical perspectives. Candida and Candidiasis (Calderone R., ed), pp. 15-25. ASM Press, Washington, DC.
20. Camacho D, Gasparetto A & Svidzinski T (2007) The effect of chlorhexidine and gentian violet on the adherence of Candida spp. to urinary catheters. Mycopathology163: 261-266.
21. Cannon RD & Chaffin WL (1999) Oral colonization by Candida albicans. Crit Rev Oral Biol M10: 359-383.
22. Carvalho A, Costa-De-Oliveira S, Martins ML, Pina-Vaz C, Rodrigues AG, Ludovico P & Rodrigues F (2007) Multiplex PCR identification of eight clinically relevant Candida species. Med Mycol45: 619-627.
23. Cassone A, De Bernardis F, Pontieri E, Carruba G, Girmenia C, Martino P, Fernandez-Rodriguez M, Quindos G & Ponton J (1995) Biotype diversity of Candida parapsilosis and its relationship to the clinical source and experimental pathogenicity. J Infect Dis171: 967-975.
24. Chaffin WL (2008) Candida albicans cell wall proteins. Microbiol Mol Biol R72: 495-544.
25. Chakrabarti A, Nayak N & Talwar P (1991) In vitro proteinase production by Candida species. Mycopathology114: 163-168.
26. Chakrabarti A, Chatterjee SS, Rao KLN, Zameer MM, Shivaprakash MR, Singhi S, Singh R & Varma SC (2009) Recent experience with fungaemia: change in species distribution and azole resistance. Scand J Infect Dis 41: 275-284.
27. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T & Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 5385-5394.
28. Chen S, Tong Z, Lee O, Halliday C, Playford E, Widmer F, Kong F, Wu C & Sorrell T (2008) Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol27: 201-208.
29. Chen YC, Eisner JD, Kattar MM, Rassoulian-Barrett SL, LaFe K, Yarfitz SL, Limaye AP & Cookson BT (2000) Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 3 region of the rRNA genes. J Clin Microbiol38: 2302-2310.
30. Colombo AL, Perfect J, DiNubile M, Bartizal K, Motyl M, Hicks P, Lupinacci R, Sable C & Kartsonis N (2003) Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur J Clin Microbiol 22: 470-474.
31. Colombo AL, Guimarães T, Silva LRBF, Monfardini LPDA, Cunha AKB, Rady P, Alves T & Rosas RC (2007) Prospective Observational Study of Candidemia in São Paulo, Brazil: Incidence Rate, Epidemiology, and Predictors of Mortality. Infect Cont Hosp Ep 28: 570-576.
32. Contreras I, Ponton J & Quindos G (1994) Prevalence of Candida parapsilosis in the oral cavities of infants in Spain. Clin Infect Dis18: 480-481.
33. Cormack BP, Ghori N & Falkow S (1999) An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science285: 578-582.
34. Costa-de-Oliveira S, Pina-Vaz C, Mendonça D & Rodrigues AG (2008) A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur J Clin Microbiol27: 365-374.
35. Dagdeviren M, Cerikcioglu N & Karavus M (2005) Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses48: 321-326.
36. De Las Penas A, Pan SJ, Castano I, Alder J, Cregg R & Cormack BP (2003) Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1- and SIR-dependent transcriptional silencing. Genes Dev17: 2245-2258.
37. Diekema DJ, Messer SA, Brueggemann ABet al. (2002) Epidemiology of candidemia: 3-year results from the Emerging Infections and the Epidemiology of Iowa Organisms Study. J Clin Microbiol 40: 1298-1302.
38. Domergue R, Castano I, De Las Penas A, Zupancic M, Lockatell V, Hebel JR, Johnson D & Cormack BP (2005) Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science308: 866-870.
39. Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
40. Dorko E, Pilipčinec E & Tkáčiková L (2002) Candidal urinary tract infections caused by non-albicans Candida species. Folia Microbiol47: 182-184.
41. Dostal J, Dlouha H, Malon P, Pichová I & Hruskova-Heidingsfeldova O (2005) The precursor of secreted aspartic proteinase Sapp1p from Candida parapsilosis can be activated both autocatalytically and by a membrane-bound processing proteinase. Biol Chem386: 791-799.
42. Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol11: 30-36.
43. Eggimann P, Garbino J & Pittet D (2003) Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis3: 685-702.
44. Ellepola ANB & Morrison CJ (2005) Laboratory diagnosis of invasive Candidiasis. J Microbiol43: 65-84.
45. Enger L, Joly S, Pulol C, Simonson M, Pfaller MA & Soll R (2001) Cloning and characterization of a complex DNA fingerprinting probe for Candida parapsilosis. J Clin Microbiol39: 658-669.
46. Fell JW, Statzell-Tallman A, Lutz MJ & Kurtzman (1992) Partial rRNA sequences in marine yeasts; a model for identification of marine eukaryotes. Mol Mar Biol Biotech1: 175-186.
47. Fidel PL, Vazquez JA & Sobel JD (1999) Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12: 80-96.
48. Fu Y, Ibrahim AS, Fonzi W, Zhou X, Ramos CF & Ghannoum MA (1997) Cloning and characterization of a gene (LIPI) which encodes a lipase from the pathogenic yeast Candida albicans. Microbiology143: 331-340.
49. Furlaneto-Maia L, Specian A, Bizerra F, Oliveira M & Furlaneto M (2007) In vitro evaluation of putative virulence attributes of oral isolates of Candida spp. obtained from elderly healthy individuals. Mycopathologia166: 209-217.
50. Fusek M, Smith EA, Monod M, Dunn BM & Foundling SI (1994) Extracellular aspartic proteinases from Candida albicans, Candida tropicalis, and Candidaparapsilosis yeasts differ substantially in their specificities. Biochemistry33: 9791-9799.
51. Gácser A, Schafer W, Nosanchuk JS, Salomon S & Nosanchuk JD (2007a) Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet Biol44: 1336-1341.
52. Gácser A, Trofa D, Schafer W & Nosanchuk JD (2007b) Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. J Clin Invest117: 3049-3058.
53. Galan-Ladero MA, Blanco MT, Sacristan B, Fernandez-Calderan MC, Perez-Giraldo C & Gomez-Garcia AC (2010) Enzymatic activities of Candidatropicalis isolated from hospitalized patients. Med Mycol48: 207-210.
54. Ghannoum MA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev13: 122-143.
55. Ghannoum MA & Rice LB (1999) Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501-517.
56. Gonzalez GM, Elizondo M & Ayala J (2008) Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J Clin Microbiol 46: 2902-2905.
57. Gonzalez Gravina H, Gonzalez de Moran E, Zambrano O, Lozano Chourio M, Rodriguez de Valero S, Robertis S & Mesa L (2007) Oral candidiasis in children and adolescents with cancer. Identification of Candida spp. Med Oral Patol Oral Cir Bucal12: 419-423.
58. Gow NAR, Brown AJP & Odds FC (2002) Fungal morphogenesis and host invasion. Curr Opin Microbiol5: 366-371.
59. Groll AH, Piscitelli SC & Walsh TJ (2001) Antifungal pharmacodynamics: concentration-effect relationship in vitro and in vivo. Pharmacotherapy 21: 133S-148S.
60. Hagerty JA, Ortiz J, Reich D & Manzarbeitia C (2003) Fungal infections in solid organ transplant patients. Surg Infect (Larchmt)4: 263-271.
61. Hajjeh RA, Sofair AN, Harrison LHet al. (2004) Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol42: 1519-1527.
62. Hasan F, Xess I, Wang X, Jain N & Fries BC (2009) Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect11: 753-761.
63. Hawser SP & Douglas LJ (1994) Biofilm Formation by Candida species on the surface of catheter materials in vitro. Infect Immun62: 915-921.
64. Hawser SP & Douglas LJ (1995) Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Ch39: 2128-2131.
65. Haynes KA (2001) Virulence in Candida species. Trends Microbiol9: 591-596.
66. Haynes KA & Westerneng TJ (1996) Rapid identification of Candida albicans, C. glabrata, C. parapsilosis and C. krusei by species-specific PCR of large subunit ribosomal DNA. J Med Microbiol44: 390-396.
67. Hazen KC, Plotkin BJ & Klimas DM (1986) Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata. Infect Immun54: 269-271.
68. Henriques M, Gasparetto K, Azeredo J & Oliveira R (2002) Experimental methodology to quantify Candida albicans cell surface hydrophobicity. Biotechnol Lett24: 1111-1115.
69. Hoyer LL, Fundyga R, Hecht JE, Kapteyn JC, Klis FM & Arnold J (2001) Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS family. Genetics157: 1555-1567.
70. Isenberg HD, Tucci V, Cintron F, Singer C, Weinstein GS & Tyras DH (1989) Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol27: 2426-2428.
71. Jain N, Kohli R, Cook E, Gialanella P, Chang T & Fries BC (2007) Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microb73: 1697-1703.
72. Jayatilake JA, Samaranayake YH, Cheung LK & Samaranayake LP (2006) Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicansCandida species in reconstituted human oral epithelium. J Oral Pathol Med35: 481-491.
73. Joachim H & Polayes S (1940) Subculture endocarditis and systemic mycosis (monilia). JAMA115: 205-208.
74. Kantarciǒlu AS & Yücel A (2002) Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses45: 160-165.
75. Kauffman CA, Vazquez JA, Sobel JDet al. (2000) Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis30: 14-18.
76. Kiehn TE, Edwards FF & Armstrong D (1980) The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol73: 518-521.
77. Kikutani H & Makino S (1992) The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51: 285-322.
78. Kobayashi C, Fernandes ODFL, Miranda K, Sousa E & Silva MRR (2004) Candiduria in hospital patients: a study prospective. Mycopathologia 158: 49-52.
79. Kojic EM & Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev17: 255-267.
80. Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP & Raad II (2001) Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis33: 1676-1681.
81. Kossoff EH, Buescher ES & Karlowicz MG (1998) Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 17: 504-508.
82. Krcmery V (1999a) Torulopsis glabrata an emerging yeast pathogen in cancer patients. Int J Antimicrob Ag11: 1-6.
83. Krcmery V & Barnes AJ (2002) Non-albicansCandida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50: 243-260.
84. Krcmery VJ (1999b) Candidemia in cancer patients: risk factors and outcome in 140 episodes from a single cancer institution. Acta Chemoth 5: 133-145.
85. Kucharínová S, Tournu H, Holtappels M, Van Dijck P & Lagrou K (2010) In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated candidiasis. Antimicrob Agents Ch54: 4474-4475.
86. Kuhn DM, Chandra J, Mukherjee PK & Ghannoum MA (2002) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun70: 878-888.
87. Kumamoto CA (2002) Candida biofilms. Curr Opin Microbiol5: 608-611.
88. Kumar VG, Latha R, Vedhagiri K, Sathiamoorthi T, Jayarani G, Sasikala R, Selvin J & Natarajaseenivasan K (2009) Phospholipase C, proteinase and hemolytic activities of Candida spp. isolated from pulmonary tuberculosis patients. J Mycol Med19: 3-10.
89. Larone D (2002) Medically Important Fungi; A Guide to Identification. 4th edn. ASM Press, Washington.
90. Lass-Flörl C (2009) The changing face of epidemiology of invasive fungal disease in Europe. Mycoses52: 197-205.
91. Lattif AA, Mukherjee PK, Chandra J, Swindell K, Lockhart SR, Diekema DJ, Pfaller MA & Ghannoum MA (2009) Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. Int J Med Microbiol300: 265-270.
92. Lermann U & Morschhauser J (2008) Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans. Microbiology154: 3281-3295.
93. Lewis K (2001) Ridlle of biofilm resistance. Antimicrob Agent Ch45: 999-1007.
94. Liguori G, Onofrio V, Lucariello A, Galle F, Signoriello G, Colella G, D'Amora M & Rossano F (2009) Oral candidiasis: a comparison between conventional methods and multiplex polymerase chain reaction for species identification. Oral Microbiol Immun 24: 76-78.
95. Luo G, Samaranayake LP, Cheung BPK & Tang G (2004) Reverse transcriptase polymerase chain reaction (RT-PCR) detection of HLP gene expression in Candida glabrata and its possible role in vitro haemolysin production. APMIS112: 283-290.
96. Lupetti A, Danesi R, Campa Met al. (2002) Molecular basis of resistance to azole antifungals. Trends Mol Med8: 76-81.
97. Luque AG, Biasoli MS, Tosello ME, Binolfi A, Lupo S & Magaro HM (2009) Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina. Mycoses52: 53-59.
98. Manns JM, Mosser DM & Buckley HR (1994) Production of a hemolytic factor by Candida albicans. Infect Immun62: 5154-5156.
99. Manzano-Gayosso P, Hernandez-Hernandez F, Zavala-Velasquez N, Mendez-Tovar LJ, Naquid-Narvaez JM, Torres-Rodriguez JM & Lopez-Martinez R (2008) Candiduria in type 2 diabetes mellitus patients and its clinical significance. Candida spp. antifungal susceptibility. Rev Med Inst Mex Seguro Soc46: 603-610.
100. Martin MV (1979) Germ-tube formation by oral strains of Candida tropicalis. J Med Microbiol12: 187-194.
101. Martins M, Henriques M, Ribeiro AP, Fernandes R, Goncalves V, Seabra A, Azeredo J & Oliveira R (2010a) Oral Candida carriage of patients attending a dental clinic in Braga, Portugal. Rev Iberoam Micol27: 119-124.
102. Martins M, Uppuluri P, Thems DD, Cleary IA, Henriques M, Lopez-Ribot LJ & Oliveira R (2010b) Presence of extracellular DNA in the Candida albicans matrix and its contribution to biofilms. Mycopathologia5: 323-331.
103. Merkerova M, Dostal J, Hradilek M, Pichova I & Hruskova-Heidingsfeldova O (2006) Cloning and characterization of Sapp2p, the second aspartic proteinase isoenzyme from Candida parapsilosis. FEMS Yeast Res6: 1018-1026.
104. Messer SA, Jones RN & Fritsche TR (2006) International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol 44: 1782-1787.
105. Miranda LN, van der Heijden IM, Costa SF, Sousa AP, Sienra RA, Gobara S, Santos CR, Lobo RD, Pessoa VP & Levin AS (2009) Candida colonisation as a source for candidaemia. J Hosp Infect72: 9-16.
106. Mukherjee PK & Chandra J (2004) Candida biofilm resistance. Drug Resist Update7: 301-309.
107. Naglik JR, Moyes D, Makwana Jet al. (2008) Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology154: 3266-3280.
108. Negri M, Gonçalves V, Silva S, Henriques M, Azeredo J & Oliveira R (2010a) Crystal violet staining to quantify Candida adhesion to epithelial cells. Brit J Biomed Sci67: 120-125.
109. Negri M, Martins M, Henriques M, Svidzinski T, Azeredo J & Oliveira R (2010b) Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia169: 175-182.
110. Neugnot V, Moulin G, Dubreucq E & Bigey F (2002) The lipase/acyltransferase from Candida parapsilosis: molecular cloning and characterization of purified recombinant enzymes. Eur J Biochem 269: 1734-1745.
111. Nosek J, Holesova Z, Kosa P, Gácser A & Tomaska L (2009) Biology and genetics of the pathogenic yeast Candida parapsilosis. Curr Genet55: 497-509.
112. Nucci M & Colombo AL (2007) Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Micr Infec Dis 58: 77-82.
113. Odds F (1988) Candida and Candidiasis. 2nd edn. Bailliere Tindall, London.
114. Orazio R, Scordino F, Pernice I, Passo CL & Criseo G (2009) A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis. J Microbiol Meth79: 117-120.
115. Panagoda GJ, Ellepola ANB & Samaranayake LP (2001) Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity. Mycoses44: 29-35.
116. Passos XS, Sales WS, Maciel PJ, Costa CR, Miranda KC, Lemos JA, Batista MA & Silva MRR (2005) Candida colonization in intensive care unit patients' urine. Mem I Oswaldo Cruz100: 925-928.
117. Pfaller MA (1992) Laboratory aids in the diagnosis of invasive candidiasis. Mycopathology120: 65-72.
118. Pfaller MA & Diekema DJ (2007) Epidemiology of invasive Candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
119. Pfaller MA, Jones RN, Messer SA, Edmond M & Wenzel RP (1998) National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Micr Infec Dis 31: 327-332.
120. Pfaller MA, Boyken L, Hollis RJet al. (2005) In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9, 359 isolates tested by clinical and laboratory standards institute broth microdilution methods. J Clin Microbiol 43: 3807-3810.
121. Pfaller MA, Castanheira M, Messer AS, Moet GJ & Jones RN (2010) Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). Diagn Micr Infec Dis 68: 278-283.
122. Pichová I, Pavlickova L, Dostal J, Dolejsi E, Hruskova-Heidingsfeldova O, Weber J, Ruml T & Soucek M (2001) Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae: inhibition with peptidomimetic inhibitors. Eur J Biochem 268: 2669-2677.
123. Polak AM, Scholer HJ & Wall M (1982) Combination of action of experimental candidiasis, cryptococcosis, and aspergilosis in mice. Chemotherapy28: 461-479.
124. Ramage G, Wickes BL & Lopez-Ribot JL (2001) Biofilms of Candida albicans and their associated resistance antifungal agents. Antimicrob Agents Ch20: 43-44.
125. Ramage G, Martinez JP & Lopez-Ribot JL (2006) Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6: 979-986.
126. Redding SW, Kirkpatrick WR, Coco BJ, Sadkowski L, Fothergill AW, Rinaldi MG, Eng TY & Patterson TF (2002) Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer. J Clin Microbiol40: 1879-1881.
127. Rex JH, Rinaldi MG, Galgiani JN & Pfaller MA (1995) Resistance of Candida species to fluconazole. Antimicrob Agents Ch39: 1-8.
128. Rho J, Shin J, Song J, Park M, Kee S, Jang S, Park Y, Suh S & Ryang D (2004) Molecular investigation of two consecutive nosocomial clusters of Candidatropicalis candiduria using pulsed-field gel electrophoresis. J Microbiol42: 80-86.
129. Rigby S, Procop GW, Haase Get al. (2002) Fluorescence In Situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J Clin Microbiol40: 2182-2186.
130. Roling EE, Klepser ME, Wasson A, Lewis RE, Ernest EJ & Pfaller MA (2002) Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY303366) alone and in combination against Candida spp and Cryptococcus neoformans via time kill methods. Diagn Micr Infec Dis2: 73-85.
131. Ruan S & Hsueh P (2009) Invasive candidiasis: an overview from Taiwan. J Med Assoc 108: 443-451.
132. Rüchel R (1999) Proteinases of pathogenic fungi. Mycoses42: 48-52.
133. Rüchel R, de Bernardis F, Ray TL, Sullivan PA & Cole GT (1992) Candida acid proteinases. J Med Vet Mycol30: 123-132.
134. Ruping MJ, Vehreschild JJ & Cornely OA (2008) Patients at high risk of invasive fungal infections: when and how to treat. Drugs 68: 1941-1962.
135. Saiman L, Ludington E, Dawson JDet al. (2001) Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J20: 1119-1124.
136. Samaranayake LP, Fidel PL, Naglik JR, Sweet SP, Teanpaisan R, Coogan MM, Blignaut E & Wanzala P (2002) Fungal infections associated with HIV infection. Oral Dis8: 151-160.
137. Samaranayake YH & Samaranayake LP (2001) Experimental oral candidiasis in animal models. Clin Microbial Rev14: 389-429.
138. Sampaio P, Gusmão L, Correia A, Alves C, Rodrigues AG, Pina-Vaz C, Amorim A & Pais C (2005) New microsatellite multiplex PCR for Candida albicans strain typing reveals microevolutionary changes. J Clin Microbiol43: 3869-3876.
139. Sanglard D & Odds FC (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2: 73-85.
140. Shin JH, Kee SJ, Shin MG, Kim SH, Shin DH, Lee SK, Suh SP & Ryang DW (2002) Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40: 1244-1248.
141. Silva S, Henriques M, Martins A, Oliveira R, Williams D & Azeredo J (2009a) Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol 47: 681-689.
142. Silva S, Henriques M, Oliveira R, Azeredo J, Malic S, Hooper SJ & Williams DW (2009b) Characterization of Candida parapsilosis infection of an in vitro reconstituted human oral epithelium. Eur J Oral Sci117: 669-675.
143. Silva S, Hooper SJ, Henriques M, Oliveira R, Azeredo J & Williams DW (2010a) The role of secreted aspartyl proteinases in Candida tropicalis invasion and damage of oral mucosa. Clin Microbiol Infec17: 264-272.
144. Silva S, Negri M, Henriques M, Oliveira R, Williams D & Azeredo J (2010b) Silicone colonisation by non-Candida albicans Candida species in the presence of urine. J Med Microbiol59: 747-754.
145. Solomon SL, Khabbaz RF, Parker RH, Anderson RL, Geraghty MA, Furman RM & Martone WJ (1984) An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis149: 98-102.
146. Scozo G, Kardos G, McNicholas PMet al. (2007) Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species. J Antimicrob Chemoth60: 1004-1009.
147. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE & Coleman DC (1995) Candida dubliniensis sp. nov: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141: 1507-1521.
148. Symersky J, Monod M & Foundling SI (1997) High-resolution structure of the extracellular aspartic proteinase from Candida tropicalis yeast. Biochemistry36: 12700-12710.
149. Tavanti A, Davidson AD, Gow NARet al. (2005) Candida ortopsilosis and Candida metapsilosis spp. nov to replace Candida parapsilosis groups II and III. J Clin Microbiol43: 284-292.
150. Togni G, Sanglard D, Falchetto R & Monod M (1991) Isolation and nucleotide sequence of the extracellular acid protease gene (ACP) from the yeast Candida tropicalis. FEBS Lett286: 181-185.
151. Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L & Grillot R (2006) Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Ag 27: 359-366.
152. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA & Gaynes RP (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis35: 627-630.
153. Trofa D, Gacser A & Nosanchuk JD (2008) Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev21: 606-625.
154. Vandeputte P, Tronchin C, Berges Tet al. (2007) Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth. Antimicrob Agents Ch51: 982-990.
155. Vazquez JA, Sanchez V, Dmuchowski C, Dembry LM, Sobel JD & Zervos MJ (1993) Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 168: 195-201.
156. Vermes A, Guchelaar HJ & Dankert J (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemoth 46: 171-179.
157. Verweij PE, Breuker IM, Rijs AJ & Meis JF (1999) Comparative study of seven commercial yeast identification systems. J Clin Pathol52: 271-273.
158. Vilain S, Pretorius JM, Theron J & Brozel VS (2009) DNA as an adhesin: Bacillus cereus requires extracellular DNA to form biofilm. Appl Environ Microb 75: 2861-2868.
159. Voss A, Hollis RJ, Pfaller MA, Wenzel RP & Doebbeling BN (1994) Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol32: 975-980.
160. Walsh TJ (2002) Echinocandins - an advance in the primary treatment of invasive candidiasis. New Engl J Med347: 2070-2072.
161. Watanabe T, Takano M, Murakami M, Tanaka H, Matsuhisa A, Nakao N, Mikami T, Suzuki M & Matsumoto T (1999) Characterization of a haemolytic factor from Candida albicans. Microbiology145: 689-694.
162. Weems JJ (1992) Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 14: 756-766.
163. Williams DW, Wilson MJ, Lewis MA & Potts (1995) Identification of Candida species by PCR and restriction fragment polymorphism analysis of intergenic spacer regions of ribosomal DNA. J Clin Microbiol33: 2476-2479.
164. Yoshio O & Kouji G (2006) Antigenicity of Candida tropicalis strain cells cultured at 27 and 37°C. FEMS Immunol Med Mic46: 438-443.
165. Zaugg C, Borg-von Zepelin M, Reichard U, Sanglard D & Monod M (2001) Secreted aspartic proteinase family of Candida tropicalis. Infect Immun69: 405-412.